Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Wan-di Feng"'
Autor:
Dong-Ni Liu, Wen-Fang Zhang, Wan-Di Feng, Shuang Xu, Dan-Hong Feng, Fu-Hang Song, Hua-Wei Zhang, Lian-Hua Fang, Guan-Hua Du, Yue-Hua Wang
Publikováno v:
Marine Drugs, Vol 22, Iss 9, p 391 (2024)
Glioblastoma represents the predominant and a highly aggressive primary neoplasm of the central nervous system that has an abnormal metabolism. Our previous study showed that chrysomycin A (Chr-A) curbed glioblastoma progression in vitro and in vivo.
Externí odkaz:
https://doaj.org/article/7aa6823baaea497c8fe1284ff8aa02fb
Autor:
Hao-Jie Ma, Cong Gai, Yuan Chai, Wan-Di Feng, Cui-Cui Cheng, Jin-Kun Zhang, Yu-Xin Zhang, Lu-Ping Yang, Zhen-Yu Guo, Yu-Shan Gao, Hong-Mei Sun
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
As a typical traditional Chinese medicine, Bu-Yin-Qian-Zheng Formula (BYQZF) has been shown to have neuroprotective effects in patients with Parkinson’s disease (PD), particularly by ameliorating mitochondrial dysfunction and regulating expression
Externí odkaz:
https://doaj.org/article/f7a4b2fed43a41e38a0c7a4bdcea5ae9
Autor:
Cong Gai, Wan-Di Feng, Tian-Yao Qiang, Hao-Jie Ma, Yuan Chai, Shu-Jing Zhang, Zhen-Yu Guo, Jing-Hong Hu, Hong-Mei Sun
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
To investigate the effect of Da-Bu-Yin-Wan and Qian-Zheng-San (DBYW and QZS) on mitochondrial mass in Parkinson’s disease (PD) cell model induced by 1-Methyl-4-phenylpyridinium Ion (MPP+). The SH-SY5Y cell was selected and treated with MPP+. The PD
Externí odkaz:
https://doaj.org/article/ac344c60fece47a8ba6c4f1f780f2737
Autor:
Yi Zhang, Xiao-Gang Gong, Hong-Mei Sun, Zhen-Yu Guo, Jing-Hong Hu, Yuan-Yuan Wang, Wan-Di Feng, Lin Li, Ping Li, Zhen-Zhen Wang, Nai-Hong Chen
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Da-Bu-Yin-Wan (DBYW) is recorded originally in China over six centuries ago, and it is used to treat Parkinson’s disease (PD) clinically in recent decades. DJ-1 is a homodimeric protein linked to early-onset PD, and found in the mitochondria. In ad
Externí odkaz:
https://doaj.org/article/aa8914d65f6a4bc0b7b4ef9ba34899ec
Autor:
Tong Luo, Xin Jia, Wan-di Feng, Jin-yong Wang, Fang Xie, Ling-dong Kong, Xue-jiao Wang, Rui Lian, Xia Liu, Ying-jie Chu, Yao Wang, An-long Xu
Publikováno v:
Acta Pharmacologica Sinica.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::274ec0a0d6cf3bf15b658d9309f05437
https://doi.org/10.1038/s41401-023-01094-7
https://doi.org/10.1038/s41401-023-01094-7
Autor:
Wan-di Feng, Yao Wang, Tong Luo, Xin Jia, Cui-qin Cheng, Hao-jia Wang, Mei-qi Zhang, Qi-qi Li, Xue-jiao Wang, Yi-ying Li, Jin-yong Wang, Guang-rui Huang, Ting Wang, An-long Xu
Publikováno v:
Acta pharmacologica Sinica.
Recent evidence shows that targeting NLRP3 inflammasome activation is an important means to treat inflammasome-driven diseases. Scoparone, a natural compound isolated from the Chinese herb Artemisia capillaris Thunb, has anti-inflammatory activity. I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5314734e41a02bc63ca1b8a6acd7c9c0
https://pubmed.ncbi.nlm.nih.gov/36522512
https://pubmed.ncbi.nlm.nih.gov/36522512
Autor:
Jin-Kun Zhang, Yuxin Zhang, Wan-Di Feng, Hao-Jie Ma, Lu-Ping Yang, Hong-Mei Sun, Cong Gai, Yushan Gao, Zhen-Yu Guo, Cui-Cui Cheng
Publikováno v:
Journal of Traditional Chinese Medical Sciences, Vol 7, Iss 3, Pp 274-282 (2020)
Objective Buyinqianzheng Formula (BYQZF) is clinically employed in traditional Chinese medicine to treat Parkinson’s disease (PD) by improving mitochondrial dysfunction. However, the underlying mechanisms by which BYQZF affects mitochondrial morpho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd95d839d12382f80bfcd0014b7cd8ce
http://www.sciencedirect.com/science/article/pii/S2095754820300697
http://www.sciencedirect.com/science/article/pii/S2095754820300697
Autor:
Hong-Mei Sun, Jing Feng, Yi Zhang, Zhen-Yu Guo, Yuan Chai, Ling Ma, Cong Gai, Tian-Yao Qiang, Wan-Di Feng, Hao-Jie Ma
Publikováno v:
Journal of Traditional Chinese Medical Sciences, Vol 6, Iss 1, Pp 26-34 (2019)
Objective: To summarize the current clinical evidence related to the therapeutic effects and safety of adjuvant scalp electro-acupuncture (SEA) treatment for Parkinson's disease in China. Methods: Following the PRISMA statement, seven electronic data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f2cae4159759132396ec2c7b16188c9
http://www.sciencedirect.com/science/article/pii/S2095754818301844
http://www.sciencedirect.com/science/article/pii/S2095754818301844
Autor:
Wan-Di Feng, Cong Gai, Jing-Hong Hu, Tian-Yao Qiang, Zhen-Yu Guo, Hong-Mei Sun, Hao-Jie Ma, Yuan Chai, Shujing Zhang
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 10 (2019)
Frontiers in Pharmacology, Vol 10 (2019)
To investigate the effect of Da-Bu-Yin-Wan and Qian-Zheng-San (DBYW and QZS) on mitochondrial mass in Parkinson's disease (PD) cell model induced by 1-Methyl-4-phenylpyridinium Ion (MPP+). The SH-SY5Y cell was selected and treated with MPP+. The PD m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4caf7069dff311f7c334c62d611f41aa
http://europepmc.org/articles/PMC6491701
http://europepmc.org/articles/PMC6491701
Publikováno v:
Medicine. 100:e23010
Background Parkinson disease (PD) is a worldwide spread neurodegenerative disorder. Dopamine replacement therapy is currently the mainstream treatment, which can alleviate the symptoms but induces motor complications. Electroacupuncture (EA) is benef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77c1da3e2403c4f644485bdeb4a9b69d
https://doi.org/10.1097/md.0000000000023010
https://doi.org/10.1097/md.0000000000023010